Journal profile · Medicine, General & Internal
Presse Medicale
ISSN 0755-4982 · eISSN 2213-0276 · Elsevier Masson · FRANCE · Weekly · Founded 1983
Presse Medicale: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.79; hybrid open access; APC about USD 2,320; median 83 days to acceptance (66 articles, last 24 months); community-reported acceptance: easy; 52 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Presse Medicale is published by Elsevier Masson and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health, Medicine and Society, Vasculitis and related conditions and Healthcare Systems and Practices, together about 33.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Designed to foster excellence in internal medical practice and facilitate access to an international readership, La Presse Médicale - Quarterly Medical Review becamed a strictly online and English language journal. Each issue is headed by an international expert and dedicated to a specific topic, with an editorial and several solicited papers. La Presse Médicale - Quarterly Medical Review is indexed in the most prestigious databases.2020 specific topics: IgG4 related disease - Interstitial lung diseases - Vasculitis - Tatoos -Next specific topics: Multiple Sclerosis - Scleroderma - Lipodystrophy -Modern Pandemics - Inflammatory Bowel Disease -TransplantationManuscripts may be submitted in English.
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Editor-in-chief Brigitte Dreno NantesPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health, Medicine and SocietyHealth Professions13.9%
- Vasculitis and related conditionsMedicine10.2%
- Healthcare Systems and PracticesHealth Professions9.4%
- Venous Thromboembolism Diagnosis and ManagementMedicine4.3%
- Systemic Lupus Erythematosus ResearchMedicine4.3%
- Liver Disease Diagnosis and TreatmentMedicine3.6%
- Coagulation, Bradykinin, Polyphosphates, and AngioedemaMedicine3.3%
- Blood Pressure and Hypertension StudiesMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.79LetPub ·
- Impact factor (publisher)
- 5Publisher website ·
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.43LetPub ·
- h-index
- 37LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 1,192OpenAlex ·
- 2-year mean citedness
- 2.53OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 27.55%LetPub ·
Volume
- Articles per year
- 40LetPub ·
Articles by year OpenAlex count · 8,585 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 9 | 7 |
| 2025 | 52 | 19 | 123 |
| 2024 | 32 | 24 | 174 |
| 2023 | 50 | 32 | 583 |
| 2022 | 52 | 25 | 723 |
| 2021 | 41 | 21 | 694 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 56 days – 163 days
- Acceptance to online
- median 26 days (66 articles)
- Submission to online
- median 121 days
- Sample
- 66 articles with submission and acceptance dates (85 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 13 daysPublisher website ·
- First decision after review
- 67 daysPublisher website ·
- Submission to acceptance
- 103 daysPublisher website ·
- Acceptance to publication
- 26 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,320 / EUR 2,120 / GBP 1,860 / JPY 287,750 | — | — | |
| Publisher website | USD 2,250 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- brief original reportShort reports of original clinical studies.Length not stated
- editorialEditorials expound opinions, describe noteworthy facts, summarize prominent studies, report news, or provide perspective. The authors are free to choose the out…main text ≤ 500 words · references ≤ 15
- editorialsEditorials expound opinions, describe noteworthy facts, summarize prominent studies, report news, or provide perspective.Length not stated
- letterThis article presents preliminary studies or short reports. Length limits: 1 200 words, 1 table and/or 1 figure, 15 references, 6 authors. No abstract.main text ≤ 200 words · figures and tables ≤ 1 · references ≤ 15
- letters to editorsThis article presents preliminary studies or short reports.Length not stated
- quarterly medical review articleThese papers (review articles or updates) are generally solicitated articles by a guest editor about a specifical internal medicine thematic.Length not stated
- recommendations, guidelinesThe article format may not allow the publication of all the data and the authors are therefore asked to prepare a condensed summary.Length not stated
- review articletables and/or figures, 100 references. Review articles The manuscript should not exceed 5000 words (word count do not need to include the abstract, referencesmain text ≤ 5,000 words · abstract ≤ 250 words · references ≤ 75
- review articlesThe manuscript should not exceed 5000 words (word count do not need to include the abstract, references, tables and figure captions), counting the title page an…Length not stated
- short communicationThis article presents concise and important new information on study results. No abstract Length limits: 1 200 words, 2 tables and/or figures, 15 referencesmain text ≤ 200 words · abstract ≤ 200 words · references ≤ 15
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Submission by invitation Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Language
- French
- Frequency
- Weekly
- Founded
- 1983
- ISSN
- 0755-4982
- Electronic ISSN
- 2213-0276
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Presse Medicale
What CAS zone is Presse Medicale in?
In the 2025 upgraded edition of the CAS Journal Ranking, Presse Medicale is in Zone 3 of Medicine, and in Zone 2 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Presse Medicale?
The latest impact factor listed by LetPub is 4.79; CiteScore 1.6, h-index 67.
How long does peer review take at Presse Medicale?
Based on the dates recorded on 66 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 56–163 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Presse Medicale?
According to LetPub and DOAJ records, Presse Medicale is indexed in SCIE and Scopus.
Is Presse Medicale open access, and what is the APC?
Presse Medicale is a hybrid journal. For open-access publication: APC about USD 2,320.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .